Using Cox's proportional hazard model and Weibull's proportional hazard model and taking into account the covariates involved, estimation of survival time was made on 94 confirmed deceased cases of unresectable pancreatic adenocarcinoma (excluding cases of cystadenocarcinoma) from the data of their admission for confirmation of diagnosis. The following results were obtained: 1)The covariates which were related to the prognosis of unresectable pancreatic adenocarcinoma were presence or absence of metastasis to the liver and lung, type of treatment for obstructive jaundice, and whether in such treatment, chemotherapy, or radiotherapy was conducted. 2)Estimation of the survival time after adjusting these factors showed that the median su...
Background: The accurate prognosis for patients with resectable pancreatic adenocarcinomas requires ...
<p>HR indicates hazard ratio; CI indicates confidence interval; EBRT, external beam radiation therap...
OBJECTIVE: Development of a prognostic tool for patients with unresectable pancreatic cancer to dist...
Using Cox's proportional hazard model and Weibull's proportional hazard model and taking into accoun...
OBJECTIVES: To define an easy-to-use model for prediction of survival time in patients with unresect...
Abstract. Objective:. This study conducted inverse probability of treatment weighting (IPTW) surviva...
AbstractBackgroundThis study attempts to define clinical predictors of survival in patients with unr...
<p>Univariate and Multivariate Cox Proportional Hazard Analysis of Factors Affecting Recurrence-free...
*<p>Median survival time in months from date of surgery to death or to most recent contact.</p
BACKGROUND: A more accurate measure of long-term survival among patients who have undergone a succes...
<p>Survival of patients with pancreatic ductal adenocarcinoma (PC) can be separated into two qualita...
<p>HR indicates hazard ratio; CI indicates confidence interval; EBRT, external beam radiation therap...
Survival data for pancreatic cancer are usually based on actuarial calculations and actual long-term...
OBJECTIVES: Patients with pancreatic adenocarcinoma often present with distant metastatic diseas...
Objectives: Pancreatic cancer is an aggressive silent killer with a median survival of a few months....
Background: The accurate prognosis for patients with resectable pancreatic adenocarcinomas requires ...
<p>HR indicates hazard ratio; CI indicates confidence interval; EBRT, external beam radiation therap...
OBJECTIVE: Development of a prognostic tool for patients with unresectable pancreatic cancer to dist...
Using Cox's proportional hazard model and Weibull's proportional hazard model and taking into accoun...
OBJECTIVES: To define an easy-to-use model for prediction of survival time in patients with unresect...
Abstract. Objective:. This study conducted inverse probability of treatment weighting (IPTW) surviva...
AbstractBackgroundThis study attempts to define clinical predictors of survival in patients with unr...
<p>Univariate and Multivariate Cox Proportional Hazard Analysis of Factors Affecting Recurrence-free...
*<p>Median survival time in months from date of surgery to death or to most recent contact.</p
BACKGROUND: A more accurate measure of long-term survival among patients who have undergone a succes...
<p>Survival of patients with pancreatic ductal adenocarcinoma (PC) can be separated into two qualita...
<p>HR indicates hazard ratio; CI indicates confidence interval; EBRT, external beam radiation therap...
Survival data for pancreatic cancer are usually based on actuarial calculations and actual long-term...
OBJECTIVES: Patients with pancreatic adenocarcinoma often present with distant metastatic diseas...
Objectives: Pancreatic cancer is an aggressive silent killer with a median survival of a few months....
Background: The accurate prognosis for patients with resectable pancreatic adenocarcinomas requires ...
<p>HR indicates hazard ratio; CI indicates confidence interval; EBRT, external beam radiation therap...
OBJECTIVE: Development of a prognostic tool for patients with unresectable pancreatic cancer to dist...